Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Evommune (EVMN) Return on Sales (2024 - 2025)

Evommune (EVMN) has disclosed Return on Sales for 2 consecutive years, with 1723.35% as the latest value for Q4 2025.

  • On a quarterly basis, Return on Sales changed N/A to 1723.35% in Q4 2025 year-over-year; TTM through Dec 2025 was 1723.35%, a N/A change, with the full-year FY2025 number at 5.98%, up 356.0% from a year prior.
  • Return on Sales was 1723.35% for Q4 2025 at Evommune, up from 972.59% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 1723.35% in Q4 2025 to a low of 972.59% in Q3 2024.